Patent ID: 9119394
Filing Date: 2015-09-01
Classification: A01N,A61K,A61P,C08G,C08L

Abstract:
1. An antimicrobial copolymer for administration to humans or animals comprising polyethylene glycol and acrolein based monomer residues derived from base-catalyzed copolymerization in an aqueous solution of: (a) polyethylene glycol (PEG) of molecular weight selected from the range of from 200 to 2000 Daltons; and (b) acrolein based monomer selected from the group consisting of acrolein and/or its acetal derived with an hydroxyl-carboxylic acid; wherein: the monomer ratio of PEG:acrolein based monomer residues within the copolymer is in the range of from 1:1 to 1:11; the copolymer remains soluble in aqueous solution; and the antimicrobial activity of the copolymer is not from release of acrolein based monomer into aqueous solution.